Target

tumor progression

3 abstracts

Abstract
Tumor treating fields (TTFields) therapy skin safety and prevention strategy using a fractionated schema protocol (3-days on/1-day off), effect on skin adverse events.
Org: Banner MD Anderson Cancer Center, Geisinger Health System Department of Pathology, Brown University - Lifespan Cancer Institute,
Abstract
Management of tumor treating fields (TTFields) therapy-related skin adverse events in pleural mesothelioma: A single center experience of TTFields therapy concomitant with chemotherapy.
Org: Mesothelioma Unit, SS Antonio e Biagio e Cesare Arrigo, Alessandria, AL, Italy, Alessandria, Italy, Oncology Unit S. Chiara Hospital, Trento, Italy,